Sign in

CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company

Damora Therapeutics, Inc.

Sign in to watch
Ticker
DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
371957007
Phone
(781) 281-9020
Business address
100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
Former names
Galecto, Inc., Galecto Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 10-Q Report Quarterly Report
  4. ARS Other Annual Report to Security Holders
  5. DEFA14A Proxy Proxy Materials
  6. DEF 14A Proxy Proxy Statement
  7. PRE 14A Proxy Proxy Statement (Preliminary)
  8. S-8 Other Securities Offered to Employees in Benefit Plans
  9. 10-K Report Annual Report
  10. SCHEDULE 13D/A Stake Beneficial Ownership Report
  11. 4 Open-market sale General Counsel sold 471 shares at $5.60 ($2,638)
  12. 4 Open-market sale Interim CFO sold 261 shares at $5.63 ($1,469)
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale Chief Executive Officer sold 1,341 shares at $5.60 ($7,510)
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G Stake Amended Statement of Ownership
  17. 10-Q Report Quarterly Report
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 8-K Event Executive or director change

Page 6 of 18 · 353 filings